Page 1 of Clinical Trials for ( Leukemia AND Myeloid AND Accelerated Phase ), 366 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
Last Updated: April 30, 2012
Condition(s): Myeloid Leukemia, Chronic, Accelerated Phase; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
2
Completed
Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia
Last Updated: April 13, 2011
Condition(s): Chronic Myelogenous Leukemia
3
Active, not recruiting
STI571 in Treating Patients With Accelerated Phase Chronic Myelogenous Leukemia
Last Updated: June 4, 2011
Condition(s): Leukemia
4
Completed
Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia (CML) in Accelerated Phase or Blast Phase (Blast Crisis)
Last Updated: May 1, 2012
Condition(s): Leukemia, Myeloid, Chronic
5
Completed
Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia
Last Updated: November 15, 2011
Condition(s): Leukemia
6
Completed
Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial
Last Updated: September 20, 2011
Condition(s): Chronic Myelogenous Leukemia
7
Completed
Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)
Last Updated: December 12, 2007
Condition(s): Chronic Myelogenous Leukemia
8
Completed
3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia
Last Updated: August 5, 2011
Condition(s): Chronic Myeloproliferative Disorders; Leukemia
9
Completed
Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia
Last Updated: October 14, 2011
Condition(s): Leukemia
10
Approved for marketing
Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Last Updated: March 14, 2011
Condition(s): Chronic Myeloid Leukemia
11
Terminated
Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia
Last Updated: May 25, 2011
Condition(s): Leukemia
12
No longer available
Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant
Last Updated: July 12, 2011
Condition(s): Chronic Myelogenous Leukemia
13
Active, not recruiting
Fludarabine Phosphate, Low-Dose Total-Body Radiation Therapy, and Peripheral Blood Stem Cell Transplant Followed By Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
Last Updated: May 7, 2012
Condition(s): Accelerated Phase Chronic Myelogenous Leukemia; Childhood Chronic Myelogenous Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Phase Chronic Myelogenous Leukemia; Relapsing Chronic Myelogenous Leukemia
14
Completed
Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)
Last Updated: May 16, 2012
Condition(s): Myeloid Leukemia, Chronic; Myeloid Leukemia, Chronic, Accelerated-Phase; Blast Phase; Myeloid Leukemia, Chronic, Chronic-Phase
15
Active, not recruiting
A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Last Updated: April 23, 2012
Condition(s): Chronic Myeloid Leukemia
16
Completed
Bortezomib in Treating Patients With Chronic Myelogenous Leukemia
Last Updated: June 4, 2011
Condition(s): Leukemia
17
Completed
Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Last Updated: July 23, 2008
Condition(s): Leukemia
18
Enrolling by invitation
Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Last Updated: January 30, 2012
Condition(s): Chronic Myeloid Leukemia
19
Active, not recruiting
An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Last Updated: April 16, 2012
Condition(s): Leukemia, Myeloid, Chronic
20
Active, not recruiting
Chemotherapy and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Last Updated: February 6, 2009
Condition(s): Leukemia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Leukemia%2C+Myeloid%2C+Accelerated+Phase

Page 1 of Clinical Trials for ( Leukemia AND Myeloid AND Accelerated Phase ), 366 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About